Main menu button

News

First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
31 Mrz 2023
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
Equity Research
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
30 Mrz 2023
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
Equity Research Risk Intelligence
Equity research Biosergen: Plans for speedy development of lead candidate
29 Mrz 2023
Equity research Biosergen: Plans for speedy development of lead candidate
Equity Research Biosergen
Swedish Real Estate Equity Snapshot
29 Mrz 2023
Swedish Real Estate Equity Snapshot
Equity Research
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
29 Mrz 2023
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
Equity Research Carlsquare
Carlsquare advised F2 Healthcare in its acquisition by Meduit, expanding revenue cycle solutions for Medicare Bad Debt
24 Mrz 2023
Carlsquare advised F2 Healthcare in its acquisition by Meduit, expanding revenue cycle solutions for Medicare Bad Debt
Deal News
Carlsquare weekly market letter: Are we back to 1929 or 2008?
22 Mrz 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research Carlsquare
Initiation of coverage, Biosergen: Make antifungals great again
20 Mrz 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research Biosergen
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
20 Mrz 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
Carlsquare weekly market letter: Tech rebounds as Fed trembles
15 Mrz 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research Carlsquare
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
15 Mrz 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
13 Mrz 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research InCoax
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
10 Mrz 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research InCoax
Carlsquare weekly market letter: Big Evening Star in S&P 500
08 Mrz 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research Carlsquare
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
06 Mrz 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research Zinzino
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
06 Mrz 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research Risk Intelligence
Carlsquare weekly market letter: Can Junk lead the way?
01 Mrz 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research Carlsquare
Research update ALM Equity: Write-downs in associates affect results
28 Feb 2023
Research update ALM Equity: Write-downs in associates affect results
Equity Research ALM Equity
First impressions Zinzino, Q4 2022: Again, profitability above our expectations
28 Feb 2023
First impressions Zinzino, Q4 2022: Again, profitability above our expectations
Equity Research Zinzino
Research Update SBB i Norden Q4 2022: Better earnings outweigh lower NAV
24 Feb 2023
Research Update SBB i Norden Q4 2022: Better earnings outweigh lower NAV
Equity Research SBB i Norden